Literature DB >> 26157543

The 2015 Oncology Drug Pipeline: Innovation Drives the Race to Cure Cancer.

Dalia Buffery1.   

Abstract

Entities:  

Year:  2015        PMID： 26157543      PMCID： PMC4489190     

Source DB:  PubMed          Journal:  Am Health Drug Benefits        ISSN： 1942-2962


× No keyword cloud information.
  1 in total

Review 1.  Breaking the Bank: Three Financing Models for Addressing the Drug Innovation Cost Crisis.

Authors:  J D Kleinke; Nancy McGee
Journal:  Am Health Drug Benefits       Date:  2015-05
  1 in total
  10 in total

1.  High-content screen using zebrafish (Danio rerio) embryos identifies a novel kinase activator and inhibitor.

Authors:  Werner J Geldenhuys; Sadie A Bergeron; Jackie E Mullins; Rowaa Aljammal; Briah L Gaasch; Wei-Chi Chen; June Yun; Lori A Hazlehurst
Journal:  Bioorg Med Chem Lett       Date:  2017-02-28       Impact factor: 2.823

Review 2.  Safe handling of oral antineoplastic medications: Focus on targeted therapeutics in the home setting.

Authors:  Yaakov Cass; Thomas H Connor; Alexander Tabachnik
Journal:  J Oncol Pharm Pract       Date:  2016-03-22       Impact factor: 1.809

3.  The European Society for Medical Oncology Magnitude of Clinical Benefit Scale in daily practice: a single institution, real-life experience at the Medical University of Vienna.

Authors:  Barbara Kiesewetter; Markus Raderer; Günther G Steger; Rupert Bartsch; Robert Pirker; Sabine Zöchbauer-Müller; Gerald Prager; Michael Krainer; Matthias Preusser; Manuela Schmidinger; Christoph C Zielinski
Journal:  ESMO Open       Date:  2016-07-04

Review 4.  Aptamer Therapeutics in Cancer: Current and Future.

Authors:  Yoshihiro Morita; Macall Leslie; Hiroyasu Kameyama; David E Volk; Takemi Tanaka
Journal:  Cancers (Basel)       Date:  2018-03-19       Impact factor: 6.639

5.  StrandAdvantage test for early-line and advanced-stage treatment decisions in solid tumors.

Authors:  Manimala Sen; Shanmukh Katragadda; Aarthi Ravichandran; Gouri Deshpande; Minothi Parulekar; Swetha Nayanala; Vikram Vittal; Weiming Shen; Melanie Phooi Nee Yong; Jemima Jacob; Sravanthi Parchuru; Kalpana Dhanuskodi; Kenneth Eyring; Pooja Agrawal; Smita Agarwal; Ashwini Shanmugam; Satish Gupta; Divya Vishwanath; Kiran Kumari; Arun K Hariharan; Sai A Balaji; Qiaoling Liang; Belen Robolledo; Vijayashree Gauribidanur Raghavendrachar; Mohammed Oomer Farooque; Cary J Buresh; Preveen Ramamoorthy; Urvashi Bahadur; Kalyanasundaram Subramanian; Ramesh Hariharan; Vamsi Veeramachaneni; Satish Sankaran; Vaijayanti Gupta
Journal:  Cancer Med       Date:  2017-04-03       Impact factor: 4.452

6.  Gene therapies development: slow progress and promising prospect.

Authors:  Eve Hanna; Cécile Rémuzat; Pascal Auquier; Mondher Toumi
Journal:  J Mark Access Health Policy       Date:  2017-01-03

Review 7.  Research Priorities and Resource Allocation in the Investigation of New Drugs for Cancer in Least Developed Countries.

Authors:  Ricardo Eccard da Silva; Angélica Amorim Amato; Débora Dornelas Belchior Costa Andrade; Alessandra Vanessa Leite E Silva; Marta Rodrigues de Carvalho; Maria Rita Carvalho Garbi Novaes
Journal:  J Oncol       Date:  2018-07-02       Impact factor: 4.375

8.  Drug cost avoidance analysis of cancer clinical trials in Spain: a study on cost contributors and their impact.

Authors:  Domingo Antonio Sánchez Martínez; Federico Salas-Lucia; Hanzi Jiang; Paula Ruiz-Carreño; José Luis Alonso Romero
Journal:  BMC Health Serv Res       Date:  2022-07-26       Impact factor: 2.908

Review 9.  Breakthroughs in modern cancer therapy and elusive cardiotoxicity: Critical research-practice gaps, challenges, and insights.

Authors:  Ping-Pin Zheng; Jin Li; Johan M Kros
Journal:  Med Res Rev       Date:  2017-09-01       Impact factor: 12.944

10.  Availability and affordability of biologic versus non-biologic anticancer medicines: a cross-sectional study in Punjab, Pakistan.

Authors:  Anum Saqib; Muhammad Rehan Sarwar; Sadia Iftikhar
Journal:  BMJ Open       Date:  2018-06-14       Impact factor: 2.692
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.